As of 2 PM, the Sensex was up 190.90 points (0.24%) at 78,175.28, while the Nifty50 gained 74.05 points (0.31%) to trade at ...

Dr. Reddy's Laboratories Ltd. closed 18.05% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's Laboratories Ltd. closed 19.44% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Natixis Advisors LLC increased its position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 422.7% in the 4th quarter, according to the company in its most recent filing with ...

Dr. Reddy's Laboratories, USA, a wholly owned subsidiary of the company, has successfully completed the sale of all issued ...

Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of biosimilars, and Dr Reddy’s Laboratories SA, a wholly-owned subsidiary of Dr Reddy’s Laboratories ...

Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, has been elected to ...

Dr. Reddy's Laboratories is among India’s leading pharmaceutical companies. The company is primarily known for manufacturing active pharmaceutical ingredients (APIs). Dr. Reddy's Laboratories ...

HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

Analyze Dr Reddy Labs (REDYc1:NS) technical analysis, including key indicators like RSI and moving averages. Track the 200-day and 50-day moving averages to assess long-term and short-term trends ...